The identification of early changes in the HD brain at the cellular and molecular level is critical for understanding pathogenesis and developing treatments for the disease. Studies by us and others in HD brain, HD mice, and with in vitro cellular models of HD show that N-terminal fragments of mutant huntingtin containing the expanded polyglutamine tract can accumulate in the nucleus or cytoplasm of neurons and cause dysfunction and cell death. Affected neurons have nuclear and cytoplasmic inclusions, cytoplasmic vacuoles, and dystrophic neurites, and may be associated with activated microglia. N-terminal huntingtin interacts with proteins involved in diverse functions. Our overall hypothesis is that mutant huntingtin impairs function at multiple sites in neurons.
The aims are: 1) To examine the regulation of huntingtin proteolysis and the accumulation of N-terminal mutant huntingtin products in neurons, 2) To determine the distribution of huntingtin and huntingtin fragments in the nucleus and a possible huntingtin interaction with a transcription repressor, 3) To determine huntingtin's association with the actin cytoskeleton and the effects of mutant huntingtin on actin- dependent cellular adhesion, 4) To examine the role of the pro-apoptotic proteins caspase 8 and BAX in mutant huntingtin induced cell death and 5) To explore the basis for microglia activation in HD. The results should help to elucidate the mechanisms underlying neuronal dysfunction and cell death in HD.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
2P50NS016367-21
Application #
6323401
Study Section
Project Start
2000-07-01
Project End
2001-06-30
Budget Start
Budget End
Support Year
21
Fiscal Year
2000
Total Cost
$80,915
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Lee, Jong-Min; Chao, Michael J; Harold, Denise et al. (2017) A modifier of Huntington's disease onset at the MLH1 locus. Hum Mol Genet 26:3859-3867
HD iPSC Consortium (2017) Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice. Nat Neurosci 20:648-660
Chao, Michael J; Gillis, Tammy; Atwal, Ranjit S et al. (2017) Haplotype-based stratification of Huntington's disease. Eur J Hum Genet 25:1202-1209
Shin, Aram; Shin, Baehyun; Shin, Jun Wan et al. (2017) Novel allele-specific quantification methods reveal no effects of adult onset CAG repeats on HTT mRNA and protein levels. Hum Mol Genet 26:1258-1267
Keum, Jae Whan; Shin, Aram; Gillis, Tammy et al. (2016) The HTT CAG-Expansion Mutation Determines Age at Death but Not Disease Duration in Huntington Disease. Am J Hum Genet 98:287-98
Correia, Kevin; Harold, Denise; Kim, Kyung-Hee et al. (2015) The Genetic Modifiers of Motor OnsetAge (GeM MOA) Website: Genome-wide Association Analysis for Genetic Modifiers of Huntington's Disease. J Huntingtons Dis 4:279-84
Lee, Jong-Min; Kim, Kyung-Hee; Shin, Aram et al. (2015) Sequence-Level Analysis of the Major European Huntington Disease Haplotype. Am J Hum Genet 97:435-44
Ramos, Eliana Marisa; Gillis, Tammy; Mysore, Jayalakshmi S et al. (2015) Haplotype analysis of the 4p16.3 region in Portuguese families with Huntington's disease. Am J Med Genet B Neuropsychiatr Genet 168B:135-43
Genetic Modifiers of Huntington’s Disease (GeM-HD) Consortium (2015) Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease. Cell 162:516-26
Biagioli, Marta; Ferrari, Francesco; Mendenhall, Eric M et al. (2015) Htt CAG repeat expansion confers pleiotropic gains of mutant huntingtin function in chromatin regulation. Hum Mol Genet 24:2442-57

Showing the most recent 10 out of 42 publications